DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20220587

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in pregnancy in a known case of antiphospholipid antibody syndrome

Nitin Pai Dhungat, Shubhdeep Kaur

Abstract


Thrombotic thrombocytopenic purpura is a haematological disorder which may be severely life-threatening. It affects the microcirculation of multiple organ systems. One of the precipitating factors for thrombotic thrombocytopenic purpura is pregnancy. The case report describes a 32 years old patient who presented with antepartum TTP-HUS and was initially treated as a case of HELLP syndrome without any improvement. The introduction of aggressive treatment with plasma transfusion and plasmapheresis has improved maternal and fetal survival rates in these cases. thrombotic thrombocytopenic purpura-haemolytic uremic syndrome is a rare complication of pregnancy and parturition, that may simulate the more common obstetric complications, namely, preeclampsia and the syndrome of haemolysis, elevated liver functions tests, low platelets. Review of the previously reported cases of pregnancy-related TTP and the current treatment options for this rare condition are also discussed. Careful diagnosis, monitoring, and treatment in congenital and acquired TTP have assisted in excellent pregnancy outcomes.


Keywords


Thrombotic thrombocytopenic purpura, HELLP syndrome, Haemolytic uremic syndrome, Plasma exchange transfusion

Full Text:

PDF

References


Sadler JE, Moake JL, Miyata T, George JN. Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2004: 407-23.

George JN. How I treat patients with thrombotic thrombocytopenic purpura. Blood. 2010;116(20): 4060-9.

Thompson CE, Damon LE, Ries CA, Linker CA. Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood. 1992;80(8):1890-5.

Gupta M, Feinberg BB, Burwick RM. Thrombotic microangiopathies of pregnancy: Differential diagnosis. Pregnancy Hypertens. 2018;12:29-34

Scully M, Cataland S, Coppo P, de la Rubia J, Friedman KD, Kremer Hovinga J, et al. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost. 2017; 15(2):312-322.

Saha M, McDaniel JK, Zheng XL. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics. J Thromb Haemost. 2017;15(10):1889-1900.

Furlan M, Lämmle B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Best Pract Res Clin Haematol. 2001;14(2):437-54.

Kinoshita S, Yoshioka A, Park YD, Ishizashi H, Konno M, Funato M, et al. Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura. Int J Hematol. 2001;74(1):101-8.

Scully M, Thomas M, Underwood M, Watson H, Langley K, Camilleri RS, et al. Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes. Blood. 2014;124(2):211-9.

Mörtzell M, Berlin G, Nilsson T, Axelsson CG, Efvergren M, Audzijoni J, et al. Analyses of data of patients with Thrombotic Microangiopathy in the WAA registry. Transfus Apher Sci. 2011;45(2):125-31.

Ferrari S, Palavra K, Gruber B, Kremer Hovinga JA, Knöbl P, et al. Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura. Haematologica. 2014;99(4):779-87.

Ferrari B, Maino A, Lotta LA, Artoni A, Pontiggia S, Trisolini SM, et al. Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case-control study. Orphanet J Rare Dis. 2014;9:193.

Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158(3):323-35.

Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117(5):1499-506.

Pontiggia S, Trisolini SM. Microangiopathic haemolytic anaemia in pregnancy. Transfus Med. Rev. 2018;32:230-6.

Watson H, Langley K, Camilleri RS. Current insights into thrombotic microangiopathies: thrombotic thrombocytopenic purpura and pregnancy. Blood. 2015;117(2)530-3.

Damon LE, Ries CA, Linker CA. Thrombotic thrombocytopenic purpura associated with oral contraceptives and factor V Leiden: a case report. Cases J. 2009;2:6611.